Reply to letter from Mayfield et al. regarding “Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA<sub>1c</sub> POCT instrument in a true clinical setting”-Reference-Cited by-同舟云学术

Reply to letter from Mayfield et al. regarding “Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA_1c POCT instrument in a true clinical setting”

Published:2022-10-26 Issue:1 Volume:61 Page:e8-e10
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Abildgaard Anders¹^ORCID,Knudsen Cindy Søndersø¹,Bjerg Lise Nørkjær²,Lund Sten³,Støy Julie³

Affiliation:

1. Department of Clinical Biochemistry , Aarhus University Hospital , Aarhus N , Denmark

2. Department of Clinical Biochemistry , Regional Hospital Central Jutland , Viborg , Denmark

3. Steno Diabetes Center Aarhus, Aarhus, University Hospital , Aarhus N , Denmark

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2022-0915/pdf

Reference11 articles.

1. Mayfield, J, Samoszuk, M. Reply to Abildgaard et al.: Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage HbA1c POCT instrument in a true clinical setting. Clin Chem Lab Med 2023;61;e5–7.https://doi.org/10.1515/cclm-2022-0835.

2. Abildgaard, A, Knudsen, CS, Bjerg, LN, Lund, S, Stoy, J. Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage HbA1c POCT instrument in a true clinical setting. Clin Chem Lab Med 2022;60:127–34. https://doi.org/10.1515/cclm-2021-0720.

3. Hirst, JA, McLellan, JH, Price, CP, English, E, Feakins, BG, Stevens, RJ, et al.. Performance of point-of-care HbA1c test devices: implications for use in clinical practice – a systematic review and meta-analysis. Clin Chem Lab Med 2017;55:167–80. https://doi.org/10.1515/cclm-2016-0303.

4. Scientific Committee on Quality Assurance (VUK). Analysekvalitetskrav til HbA1c ved brug til diagnostik og monitorering af diabetes. Available from https://dskb.dk/wp-content/uploads/2020/11/VUK-HbA1c.pdf [Accessed 15 Dec 2020].

5. Sacks, DB, Arnold, M, Bakris, GL, Bruns, DE, Horvath, AR, Kirkman, MS, et al.. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:e61–99. https://doi.org/10.2337/dc11-9998.